Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,507 | 6,453 | 27,613 | 11,424 | 9,884 |
| Receivables | 659 | N/A | N/A | 49 | 183 |
| TOTAL | $7,935 | $7,886 | $28,939 | $11,629 | $10,235 |
| Non-Current Assets | |||||
| PPE Net | 150 | 210 | 235 | 157 | 148 |
| Other Non-Current Assets | 71 | 1,188 | 2,174 | 11 | 11 |
| TOTAL | $221 | $1,398 | $2,409 | $168 | $159 |
| Total Assets | $8,156 | $9,283 | $31,348 | $11,797 | $10,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,850 | 2,803 | 1,748 | 2,058 | 268 |
| Accrued Expenses | 1,258 | 717 | 3,000 | 3,378 | 359 |
| TOTAL | $3,107 | $3,520 | $4,748 | $5,435 | $810 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 15 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2,000 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $2,000 | $15 |
| Total Liabilities | $3,107 | $3,520 | $4,748 | $7,435 | $825 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,839 | 2,172 | 1,757 | 473 | 421 |
| Common Shares | 11 | 2 | 2 | 6 | 4 |
| Retained earnings | -129,356 | -104,364 | -78,397 | -64,376 | -45,806 |
| TOTAL | $5,049 | $5,763 | $26,600 | $4,362 | $9,569 |
| Total Liabilities And Equity | $8,156 | $9,283 | $31,348 | $11,797 | $10,394 |